SEC Company Response from EMAGIN CORP (CIK 0001046995) — Nov 2, 2005
EMAGIN CORP (CIK 0001046995)
Date: Nov. 2, 2005 · CIK: 0001046995 · Accession: 0001013762-05-001454
AI Filing Summary & Sentiment
File numbers found in text: 001-15751
Show Raw Text
CORRESP
1
filename1.htm
November 1, 2005 Corresp for eMagin Corporation
October
4, 2005
United
States Securities and Exchange Commission
Division
of Corporation Finance
450
Fifth
Street, N.W.
Washington,
DC 20549
Attention: Angela
Crane,
Branch Chief
Jay
Webb,
Reviewing Accountant
Eric
Atallah, Staff Accountant
Re: eMagin
Corporation
Form
10-KSB/A for the fiscal year ended December 31, 2004
Forms
10-Q for the quarterly reports ended March 31, and June 30, 2005
Forms
10-QSB/A for the quarterly periods ended March 31, June 30, and September
30,
2004
File
No.
001-15751
Ladies
and Gentlemen:
On
behalf
of eMagin Corporation (“eMagin” or the "Company"), please accept this letter as
the Company’s response to the comments of the reviewing Staff of the Securities
and Exchange Commission (the “Commission”) as set forth in the comment letter of
September 1, 2005.
Form
10-KSB for the year ended December 31, 2004 and Amended Forms 10-QSB for
the
Quarterly Periods Ended March 31, June 30, and September 30,
2004
1.
In
light of the fact you indicate you corrected accounting errors
in your
interim 2004 financial statements in connection with warrant and
convertible debt transactions, it is unclear to us how your officers
concluded that the company’s disclosure controls and procedures were
effective at the end of each period covered by the report. Please
disclose
in reasonable detail the basis for officers’ conclusions that the
company’s disclosure controls and procedures were nonetheless effective
as
of the end of each period. We may have further comments after reviewing
your response. Revise your filings as necessary based on our
comment.
Response:
As
stated
in each of the filings mentioned above (the Form 10-KSB for the year ended
December 31, 2004 and the Amended Forms 10-QSB for the Quarterly Periods
Ended
March 31, June 30, and September 30, 2004), the Company’s officers concluded
that the Company’s disclosure controls and procedures were effective at the end
of each of the relevant periods covered by the reports.
In
connection with the audit of the Company's annual report on Form 10-KSB for
the
year ended December 31, 2004, in March 2005 it was determined that (i) the
re-pricing of certain warrants that were originally issued in an equity
transaction that the Company had completed in January 2004 should
have been classified as an equity transaction and therefore no expense should
have been recorded in connection with the re-pricing of these warrants, and
(ii)
the conversion of the debt to equity during the first quarter should have
been
classified as a debt transaction and therefore an expense should have been
recorded in connection with the conversion.
While
the
Company did, in fact, amend its quarterly reports on Form 10-QSB for the
periods
ended March 31, June 30, and September 30, 2004 in order to make these required
changes, the Company’s officers’ nevertheless concluded that the Company’s
disclosure controls and procedures were nonetheless effective as of the end
of
each such period based upon (i) the fact that such disclosure controls and
procedures include all of the actions which they felt are necessary to insure
that all of the information required to be reported in its SEC filings is
recorded, processed, and summarized, including but not limited to, (a) having
the top three officers review all contracts, press releases, and material
events
in order to determine at the time of the event whether disclosure is required
and properly accounted for and (b) seeking advisement from their outside
counsel
on disclosure requirements and (ii) the fact that each of the filings for
the
relevant periods (the Form 10-KSB for the year ended December 31, 2004 and
the
Amended Forms 10-QSB for the Quarterly Periods Ended March 31, June 30, and
September 30, 2004) contained what they believe is all of the information
required to be recorded, processed, summarized and reported, within the time
periods specified in the Commission's rules and forms. Further, the Company’s
officers’ concluded that the restatements to the Company’s interim 2004
financial statements were due to interpretations of the accounting treatment
of
such transactions, which was subsequently determined to be incorrect. The
Company’s officers’ do not believe that the restatements were in any way
attributable to any deficiency in the Company’s compliance with its disclosure
controls and procedures, and that it had appropriate controls and procedures
in
place for an organization of its size at the times in question. Accordingly,
at
the end of the periods covered by each of the relevant reports, the Company’s
officers’ believed that the Company’s disclosure controls and procedures were
effective.
The
Company understands the importance of its reporting obligations, as well
as
addressing appropriately complex financial issues with respect to these
transactions and all of the Company’s other financial matters. To this end, the
Company notes that, in June 2004, it engaged John Atherly as its Chief Financial
Officer, and in May 2005, the Company appointed Irwin Engelman to its board
of
directors and it intends to appoint Mr. Engelman as the Chairman of its Audit
Committee immediately following the completion of its upcoming annual meeting
of
shareholders. The Company has also taken the additional step of hiring a
new
Director of Finance to assist the Chief Financial Officer with the Company’s
filing and other financial reporting obligations. These persons bring a wealth
of experience and sophistication to the Company and enhance the Company’s
ability to meet its financial and other reporting obligations.
The
Company believes that these individuals will be an integral part of the
Company’s disclosure controls and procedures and that they add to the Company’s
ability to meet its continued reporting obligations within the time periods
specified in the Commission's rules and forms.
Amended
Forms 10-QSB for the Quarterly Periods Ended March 31, June 30, and September
30, 2004
Item
1. Consolidated Financial Statements
2.
Please
revise to include a header that indicates your financial statements
have
been restated. Also, label any notes that have been
restated.
Response:
We
have
revised the Company’s quarterly reports on Form 10-QSB for the periods ended
March 31, June 30, and September 30, 2004 to include a header that indicates
the
Company’s financial statements have been restated. In addition, we have labeled
Notes 1, 8, and 9 to the Company’s financial statements for the period ended
March 31, 2004 and Notes 1, 8, 9 and 13 for the periods ended June 30, 2004
and
September 30, 2004, respectively, as “restated”, where applicable. In addition,
we have restated the Preliminary Notes for the periods ended March 31, June
30,
and September 30, 2004 (see Item 3).
Note
1-Accounting Policies
Basis
of Presentation
3.
Your
quarterly restatement footnotes do not provide investors with a
clear path
between the originally filed and restated financial statement amounts.
Please revise this note in each of your 2004 Form l0-QSB’s to disclose the
specific nature of the errors and the effect of the corrections
on net
income or loss and the related per share amounts. For reference
see
paragraph 37 of APB 20.
Response:
As
requested, we have revised the Preliminary Notes to the financial statements,
where applicable, in the Company’s quarterly reports on Form 10-QSB for the
periods ended March 31, June 30, and September 30, 2004 to disclose the specific
nature of the errors and the effect of the corrections on net income or loss
and
the related per share amounts. The Preliminary Notes will be restated as
follows:
Preliminary
Note to the Company’s financial statements for the period ended March 31,
2004:
This
Amended Quarterly Report on Form 10-QSB/A is being filed to provide additional
information to clarify the corrections reported in the previously Amended
Quarterly Report on Form 10-QSB/A filed by the Company on April 12, 2005.
The
Consolidated Balance Sheets, Consolidated Statements of Operations, Consolidated
Statements of Cash Flows, and Statement of Changes in Stockholders’ Equity and
Selected Notes to Consolidated Financial Statements are labeled as “restated”
where applicable. The restatement was in connection with the preparation
of the
Company’s annual report on Form 10-KSB for the year ended December 31, 2004
where it was determined that the unamortized debt discount and the deferred
financing costs should have been recorded as interest expense. The restated
statements increase additional paid-in capital by approximately $1.67 million
representing unamortized debt discount and deferred financing costs and increase
interest expense in relation to the March 3, 2004 debt conversion of
approximately $8.567 million in principal and accrued interest. The following
table presents the impact of the corrections:
Unaudited
Consolidated Statements of Operations
Three
Months Ended March 31,
2004
Originally
Filed
Restated
Other
income (expense)
$
(3,403,110
)
$
(5,076,082
)
Net
loss
$
(4,932,972
)
$
(6,605,944
)
Basic
and diluted loss per common share
$
(0.09
)
$
(0.13
)
In
all
other material respects this Amended Quarterly Report on Form 10-QSB/A is
unchanged from the Amended Quarterly Report on Form 10-QSB/A previously filed
by
the Company on April 12, 2005.
Preliminary
Note to the Company’s financial statements for the period ended June 30,
2004:
This
Amended Quarterly Report on Form 10-QSB/A is being filed to provide additional
information to clarify the corrections reported in the previously Amended
Quarterly Report on Form 10-QSB/A filed by the Company on April 12, 2005.
The
Consolidated Balance Sheets, Consolidated Statements of Operations, Consolidated
Statements of Cash Flows, and Statement of Changes in Shareholders’ Equity and
Selected Notes to Consolidated Financial Statements are labeled as “restated”
where applicable. The restatement was in connection with the preparation
of the
Company’s annual report on Form 10-KSB for the year ended December 31, 2004
where it was determined that the unamortized debt discount and the deferred
financing costs should have been recorded as interest expense. The restated
statements reflect the changes made in the previous quarter ended March 31,
2004
filed on Form 10-QSB/A of the reclassification of approximately $1.67 million
of
unamortized debt discount and deferred financing costs from additional
paid-in-capital to interest expense in relation to the March 3, 2004 debt
conversion of approximately $8.567 million in principal and accrued interest.
The following table presents the impact of the corrections:
Unaudited
Consolidated Statements of
Operations
Three
Months Ended
June
30, 2004
Six
Months Ended
June
30, 2004
Originally
Filed
Restated
Originally
Filed
Restated
Other
income (expense)
$
8,012
$
8,012
$
(3,395,098
)
$
(5,068,069
)
Net
loss
$
(1,398,722
)
$
(1,398,722
)
$
(6,331,649
)
$
(8,004,666
)
Basic
and diluted loss per common share
$
(0.02
)
$
(0.02
)
$
(0.11
)
$
(0.14
)
In
all
other material respects this Amended Quarterly Report on Form 10-QSB/A is
unchanged from the Amended Quarterly Report on Form 10-QSB/A previously filed
by
the Company on April 12, 2005.
Preliminary
Note to the Company’s financial statements for the period ended September 30,
2004:
This
Amended Quarterly Report on Form 10-QSB/A is being filed to provide additional
information to clarify the corrections reported in the previously Amended
Quarterly Report on Form 10-QSB/A filed by the Company on April 12, 2005.
The
Consolidated Balance Sheets, Consolidated Statements of Operations, Consolidated
Statements of Cash Flows, and Statement of Changes in Shareholders’ Equity and
Selected Notes to Consolidated Financi